Status | Study |
Active, not recruiting |
Study Name: Growth Arrest in Focal Dermal Hypoplasia Condition: Focal Dermal Hypoplasia Date: 2015-06-02 |
Completed |
Study Name: Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condition: Basal Cell Carcinoma Gorlin Syndrome Nevoid Basal Cell Car Date: 2011-05-06 Interventions: Drug: LDE225 supplied as 100 m |
Withdrawn |
Study Name: Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condition: Basal Cell Carcinoma Date: 2010-07-06 Interventions: Drug: LDE225B Cream, 2x daily |
Completed |
Study Name: A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients Condition: Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients Date: 2009-08-18 Interventions: Drug: Vehicle Placebo cream |
Recruiting |
Study Name: Study of Selected X-linked Disorders: Goltz Syndrome Condition: Focal Dermal Hypoplasia (FDH) Goltz Syndr Date: 2008-06-03 |